<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-6X0DVYLF/24e98cea-30a5-4a84-92e1-1053af8d4967/HTML"><dcterms:extent>25 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-6X0DVYLF/c9685610-26c9-452a-9c6a-539614580a68/PDF"><dcterms:extent>275 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-6X0DVYLF/a9e7d870-0c2d-4065-a173-871840d59912/TEXT"><dcterms:extent>22 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2008-2025"><edm:begin xml:lang="en">2008</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-6X0DVYLF"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FQ9JBKO1" /><dcterms:issued>2010</dcterms:issued><dc:creator>Zaletel, Marjan</dc:creator><dc:format xml:lang="sl">6 strani</dc:format><dc:format xml:lang="sl">letnik:9</dc:format><dc:format xml:lang="sl">str. 47-52</dc:format><dc:format xml:lang="sl">številka:suplement 2</dc:format><dc:identifier>ISSN:1580-9315</dc:identifier><dc:identifier>COBISSID:27800793</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-6X0DVYLF</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Univerzitetni rehabilitacijski inštitut Slovenije - Soča</dc:publisher><dcterms:isPartOf xml:lang="sl">Rehabilitacija (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="en">Analgesics, Opioid</dc:subject><dc:subject xml:lang="sl">Analgetiki opioidni</dc:subject><dc:subject xml:lang="sl">Antidepresivi</dc:subject><dc:subject xml:lang="en">Antidepressive Agents</dc:subject><dc:subject xml:lang="en">Diagnosis</dc:subject><dc:subject xml:lang="en">diagnostika</dc:subject><dc:subject xml:lang="en">Dopamine Agonists</dc:subject><dc:subject xml:lang="sl">Dopaminski agonisti</dc:subject><dc:subject xml:lang="en">drug</dc:subject><dc:subject xml:lang="en">Drug Therapy</dc:subject><dc:subject xml:lang="sl">Fibromialgija</dc:subject><dc:subject xml:lang="en">Fibromyalgia</dc:subject><dc:subject xml:lang="sl">kronična bolečina</dc:subject><dc:subject xml:lang="en">Neuralgia</dc:subject><dc:subject xml:lang="sl">Nevralgija</dc:subject><dc:subject xml:lang="sl">nevropatska bolečina</dc:subject><dc:subject xml:lang="en">therapy</dc:subject><dc:subject xml:lang="sl">zdravila</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dcterms:temporal rdf:resource="2008-2025" /><dc:title xml:lang="sl">Zdravljenje fibromialgije| Treatment of fibromyalgia|</dc:title><dc:description xml:lang="sl">Fibromyalgia is a chronic syndrome that is characterized by widespread body pain. The prevalence of fibromyalgia syndrome in the general population is estimated to be 2-7%. Chronic pain is often associated with comorbidities suchas depression, chronic fatigue, anxiety. With the new evidence regarding the pathophysiology of the fibromyalgia syndrome, it has been suggested that it may be one of the neuropathic pain syndromes. Although the pathogenesis is not completely understood, it has been suggested that peripheral or central hyperexcitability at the level of spinal cord or brainstem is involved. Drugs that are successful in the treatment of neuropathic pain syndromes have also been tested for fibromyalgia. These medications include antidepressants and other neuromodulators, as well as other analgesics. Dopamine agonists are suitable for patients with fibromyalgia especially if they report restless legsyndrome. The use of conventional analgesics is not recommended. Nonfarmacological measures are also important in fibromyalgia syndrome</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-6X0DVYLF"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-6X0DVYLF" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-6X0DVYLF/c9685610-26c9-452a-9c6a-539614580a68/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Univerzitetni rehabilitacijski inštitut RS – Soča</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-6X0DVYLF/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-6X0DVYLF" /></ore:Aggregation></rdf:RDF>